OmniAb Stock: A Self-Funding Option Book On 433 Partner Programs (NASDAQ:OABI)
· seekingalpha.com
OmniAb reaches self-sustaining cash flow as its royalty platform gains traction.
Most platform biotechs ask their investors to finance the long time delay between discovering new drugs and getting paid from royalties. What I find most unique...